Figure 2.

Application of MD Anderson Cancer Center Prognostic score to our dataset. The model includes LDH >618, albumin <3.5, number of metastatic sites >2, ECOG performance status ≥1, and GI tumor type. Each variable was assigned one point, with 5 considered high risk and 0 being lowest. The median survival of patients with score of 1 (low-intermediate risk), 2 (intermediate risk), 3 (high-intermediate risk), and 4/5 (high risk) was 10.8, 6.8, 6.5, and 5.1 months, respectively (P=0.0004).